| ¿µ¹® | advanced cancer | ÇÑ±Û | ÁøÇà¾Ï |
|---|---|---|---|
| ¼³¸í | Á¶±â¾Ï¿¡ ´ëÇÑ ¸»·Î ¾ÏÀÇ °æ°ú°¡ ÁøÇàµÈ °ÍÀ» ¸»ÇÑ´Ù. |
||
| ¿µ¹® | formula | ÇÑ±Û | ó¹æ |
|---|---|---|---|
| ¼³¸í | º´À» Ä¡·áÇϱâ À§ÇÏ¿© Áõ»ó¿¡ µû¶ó ¾àÀ» Áþ´Â ¹æ¹ý, Áï, ¼ýÀÚ ¶Ç´Â ±âŸÀÇ ±âÈ£¸¦ »ç¿ëÇÏ¿© ÈÇÕ¹°, ¿¹ÄÁ´ë ÀǾàǰÀÇ Á¶¼º ¶Ç´Â Á¶Á¦¿¡ ´ëÇÏ¿© Áö½Ã¸¦ ÁÖ¸ç, ȤÀº ±â´ëÇÏ´Â °ªÀ̳ª °á°ú¸¦ ¾ò±â À§ÇÑ ÀÏÁ¤ÇÑ °úÁ¤À» Áö½ÃÇϴ ǥ±â. ÀÇ»ç-Ä¡°úÀǻ簡 ȯÀÚ¿¡ ´ëÇÏ¿© Ä¡·á»ó ¾àÁ¦¸¦ Á¶Á¦Çؼ Åõ¿©ÇÒ Çʿ䰡 ÀÖÀ» °æ¿ì¿¡´Â Áúº´ ¶Ç´Â Áõ»óÀÇ ¿¹¹æ-Ä¡·á¿¡ ÇÊ¿äÇÑ ¾à¹°À» ¼±ÅÃÇÏ¿© ±× Á¶Á¦¹ý ¹× »ç¿ë¹ýÀ» ¾à»ç¿¡°Ô Áö½ÃÇÏ°Ô µÇ´Âµ¥ ÀÌ Áö½Ã¸¦ ó¹æÀ̶ó°í ÇÑ´Ù. |
||
| ¿µ¹® | oral administration | ÇÑ±Û | °æ±¸º¹¿ë |
|---|---|---|---|
| ¼³¸í | ¾àÀ» Åõ¿©ÇÏ´Â ¹æ¹ý¿¡´Â ¿©·¯ °¡Áö°¡ ÀÖ´Ù. Å©°Ô ³ª´©¾î º¸¸é, ÀÔÀ» °ÅÃÄ À§Ã¢Àڰ踦 ÅëÇØ ³Ö´Â ¹æ¹ý°ú À§Ã¢Àڰ踦 ÅëÇÏÁö ¾Ê°í ¹Ù·Î Ç÷¾×À¸·Î ³Ö´Â ¹æ¹ýÀÌ ÀÖ´Ù. À§Ã¢Àڰ踦 ÅëÇÏÁö ¾Ê´Â ¹æ¹ýÀ¸·Î °¡Àå ÈçÇÑ ¹æ¹ýÀº Áֻ縦 ÀÌ¿ëÇÏ´Â ¹æ¹ýÀÌ´Ù. ÇÏÁö¸¸, À̿ܿ¡ Ç×¹®À» ÅëÇØ ³Ö´Â Á¾à½Ä¹æ¹ý°ú Çô¹Ø¿¡ ³Ö´Â Çô¹ØÅõ¿©¹ýµµ ÀÖ´Ù. ±×·¯³ª ´ëºÎºÐÀÇ ¾àÁ¦´Â °æ±¸º¹¿ëÀ» ÇÏ°Ô µÈ´Ù. °æ±¸º¹¿ë¿¡ ´ëÇÑ ¾àÀÚ´Â p.o.(per oral)·Î Ç¥±âÇÑ´Ù. °æ±¸º¹¿ëÁ¦ÀÇ ´ÜÁ¡Àº º¹¿ëÇÑ ¾àÁ¦°¡ À§Ã¢ÀÚ°ü°è¸¦ °ÅÄ¡¸é¼ »ç¶÷¸¶´Ù °¢±â ´Ù¸¥ Èí¼öÁ¤µµ¿Í ´ë»çÁ¤µµ¸¦ °ÅÄ¡°Ô µÇ¹Ç·Î ÀÏÁ¤ÇÑ ³óµµÀ¯Áö°¡ ¾î·Æ´Ù´Âµ¥ ÀÖ´Ù. ¶ÇÇÑ °æ±¸º¹¿ëÁ¦ÀÇ ¸ð¾çÀÌ Ä¸½¶ÇüÀÎÁö, ȤÀº °¡·çÇüÀÎÁö¿¡ µû¶ó¼µµ °°Àº ¾àÀÌÁö¸¸, ¼·Î ´Ù¸¥ È¿°ú¸¦ ³ªÅ¸³¾ ¼ö ÀÖ´Ù. |
||
| ¿µ¹® | oral cavity | ÇÑ±Û | ±¸° |
|---|---|---|---|
| ¼³¸í | ÀÔÀ» ¹ú¿©¼ ÀÔ¼Ó¿¡¼ º¼ ¼ö ÀÖ´Â °ø°£À¸·Î ÀÔõÀå, Æíµµ, ¸ñÁ¥À» º¼ ¼ö ÀÖ´Ù. ![]() |
||
| ¿µ¹® | oral cavity | ÇÑ±Û | ÀÔ¾È |
|---|---|---|---|
| ¼³¸í | ÀÔÀ» ¹ú¿©¼ ÀÔ¼Ó¿¡¼ º¼ ¼ö ÀÖ´Â °ø°£À¸·Î ÀÔõÀå, Æíµµ, ¸ñÁ¥À» º¼ ¼ö ÀÖ´Ù. |
||
| ORS | olfactory reference syndrome; oral rehydration solution; oral surgery, oral surgeon; Orthopaedic Res... |
|---|---|
| PC | avoirdupois weight [Lat. pondus civile]; packed cells; paper chromatography; paracortex; parent cell... |
| OCP | octacalcium phosphate; ocular cicatricial pemphigoid; oral case presentation; oral contraceptive pil... |
| OET | oral endotracheal tube; oral esophageal tube |
| OHI | Occupational Health Institute; operative hypertension indicator; oral hygiene index; Oral Hygiene In... |
| FF | formula fed |
|---|---|
| PND | Prenatal diagnoses |
| PD | Prenatal diagnosis |
| APN | Advanced Practice Nurse |
| ABBI | Advanced Breast Biopsy Instrumentation |
| advanced concepts torus i | <physics> A steady-state toroidal device built primarily for studies of RF heating and RF current drive. Acronym: ACT I (09 Oct 1997) |
|---|---|
| advanced fuels | <radiobiology> There are several elements or isotopes that could be fused together, besides the DT fuel mixture. Many such fuel combinations would have various advantages over DT, but it is generally more difficult to achieve fusion with these advanced fuels than with the DT mix. (09 Oct 1997) |
| advanced life support | Definitive emergency medical care that includes defibrillation, airway management, and use of drugs and medications. Compare: basic life support. (05 Mar 2000) |
| advanced multiple-beam equalization radiography | A variant of scanning equalization radiography using several X-ray beams. (05 Mar 2000) |
| advanced toroidal facility | <physics> A large stellarator device developed at Oak Ridge National Lab (ORNL), but now retired. Acronym: ATF (09 Oct 1997) |
| glycosylation end products, advanced | Products derived from the nonenzymatic reaction of glucose and proteins in vivo that exhibit a yellow-brown pigmentation and an ability to participate in protein-protein cross-linking. These substances are involved in biological processes relating to protein turnover and it is believed that their excessive accumulation contributes to the chronic complications of diabetes mellitus. (12 Dec 1998) |
| prenatal | <obstetrics> Existing or occurring before birth, with reference to the foetus. Origin: L. Natalis = natal (18 Nov 1997) |
| prenatal care | Care provided the pregnant woman in order to prevent complications, and decrease the incidence of maternal and prenatal mortality. (12 Dec 1998) |
| prenatal diagnosis | Determination of the nature of a pathological condition or disease in the postimplantation embryo, foetus, or pregnant female before birth. (12 Dec 1998) |
| prenatal exposure delayed effects | Delayed effects on offspring of maternal or foetal prenatal exposure to drugs, radiation and other physical agents, manipulation, nutrition, stress, etc. (12 Dec 1998) |
| prenatal life | That interval of life between conception and birth; in humans, usually divided into embryonic and foetal periods. (05 Mar 2000) |
| prenatal screening | Screening for the detection of foetal disease, usually by ultrasound examination or by testing amniotic fluid obtained by amniocentesis. Other screening techniques include testing maternal serum and placental biopsy. (05 Mar 2000) |
| integrated advanced information management systems | A concept, developed in 1983 under the aegis of and supported by the national library of medicine under the name of integrated academic information management systems, to provide professionals in academic health sciences centres and health sciences institutions with convenient access to an integrated and comprehensive network of knowledge. It addresses a wide cross-section of users from administrators and faculty to students and clinicians and has applications to planning, clinical and managerial decision-making, teaching, and research. It provides access to various types of clinical, management, educational, etc., databases, as well as to research and bibliographic databases. In august 1992 the name was changed from integrated academic information management systems to integrated advanced information management systems to reflect use beyond the academic milieu. (12 Dec 1998) |
| ultrasonography, prenatal | The visualization of tissues during pregnancy through recording of the echoes of ultrasonic waves directed into the body. The procedure may be applied with reference to the mother or the foetus and with reference to organs or the detection of maternal or foetal disease. (12 Dec 1998) |
| Arneth formula | The normal, approximate ratio of polymorphonuclear neutrophils, based on the number of lobes in the nuclei, as follows: 1 lobe, 5%; 2 lobes, 35%; 3 lobes, 41%; 4 lobes, 17%; 5 lobes, 2%. (05 Mar 2000) |
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|